I attended and my opinion was nothing new other than reiterating the timeline for AMP945 application for idiopathic pulmonary fibrosis + pancreatic cancer regarding trials and data collection etc. Majority was spent voting on agenda items. There was no set time provided at the end for asking questions which i found odd. Not sure if this is normal now we are using zoom. Dr Lambert read off a a script most of the time. Market seems to have reacted well though.
Ann: CEO Presentation to AGM, page-4
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
-0.001(1.69%) |
Mkt cap ! $15.75M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.5¢ | $80.83K | 1.460M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 35000 | 1 |
View Market Depth
| Last trade - 12.42pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.8¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.7¢ | 5.8¢ | 5.5¢ | 183997 | ||
| Last updated 12.42pm 21/05/2024 ? | |||||
| ATX (ASX) Chart |